The USPTO has published proposed changes to the rules governing practice before the Board of Patent Appeals and Interferences. While the proposed changes salvage a few elements from the 2008 "Final Rules" that never took effect, the USPTO plans to rescind that rules package. In its place, the USPTO has proposed a rules package that appears to strike a reasonable balance between facilitating Board review and simplifying the appeals process for applicants.
Tag Archives: Examiner’s Answer
Subscribe to This Blog
Topics
- 101
- 102
- 103
- Bilski
- Biosimilars
- Claim Construction
- District Court Decisions
- Doctrine of Equivalents
- Duty of Disclosure
- Enablement
- Federal Circuit Decisions
- Inequitable Conduct
- Infringement
- International Patent Practice
- Life Sciences Agreements
- Myriad
- Obviousness Type Double Patenting
- Patent Office Practice
- Patent Reform
- Patent Term Adjustment
- Patent Term Extension
- Patent Trials
- Personalized Medicine
- Prometheus
- Reasonable Royalty
- Reexam
- Supreme Court Decisions
- Uncategorized
- USPTO Board Decisions
- USPTO Proposed Rule Changes
- Written Description
Recent Updates
Twitter Updates
@PharmaPatents PharmaPatents' Recent Twitter Posts
- RT @LXBN: Supreme Court Finds For Monsanto In Seed Harvesting Case http://t.co/otl9Pbs0Q2 - @PharmaPatents
(about 1 day ago) - RT @priorsmart: Just read: Supreme Court Finds For Monsanto In Seed Harvesting Case - http://t.co/70U6m8vVvw [at @pharmapatents] #patent
(about 1 day ago) - New article: Supreme Court Finds For Monsanto In Seed Harvesting Case http://t.co/EAntMxrPzV ##patent
(about 2 days ago) - RT @BHoopes_Patents: Still can't believe the #CAFC #CLSBank opinion. A wonderful summary of the madness from @PharmaPatents: http://t.co/40…
(about 3 days ago) - @BHoopes_Patents Thanks!
(about 3 days ago)
